TekniPlex Healthcare, which utilises advanced materials science expertise to help deliver better patient outcomes, will provide a presentation on comprehensive, concept-to-commercialisation medical device development at Medtec China, 25-27th September in Shanghai.
TekniPlex Healthcare
On 25th September at 4:30 p.m., in Hall 2, Conf Room C, Enrique Zhang, senior product & project manager for TekniPlex Healthcare, will present From Materials to Market: Driving Innovation in Medical Tubing Technology, which emphasises the importance of materials selection and extrusion processes in medical tubing applications, and how optimising these elements can streamline manufacturing and enhance product performance.
Mr. Zhang’s presentation will highlight the latest design, development and manufacturing technologies, and explore success stories showcasing how market needs can drive materials science advancements. Attendees will learn how early-stage road-mapping strategies can lead to clearer downstream prototyping and production – including deep dives into the extrusion qualities of various med device plastics, and insight on the need for overarching, start-to-finish perspectives to meet heightening demands for tighter tolerance, smaller diameter tubing solutions.
TekniPlex Healthcare is a longstanding leader in a multitude of tubing solutions, and now offers additional product service solutions to support customers from early ideation through product development and full commercialisation. In addition to concept-to-completion production for catheters and other medical tubing solutions, the company’s prowess includes product design, prototyping, secondary processes and clean room assembly of Class II and Class II devices such as stents and stent delivery systems.
At Medtec China in Hall 2 Stand 2T001, TekniPlex Healthcare also will showcase its PTA/PTCA balloon catheter tubing for coronary and non-coronary/peripheral angioplasty applications, which are produced and extruded in ISO-certified cleanrooms and can incorporate up to three layers of specified raw materials. Ranging in balloon size from 1 to 30mm, the company’s customised balloon catheter tubing is manufactured at tight tolerances (± .0005”) with concentricity of over 90%. The tubing’s controlled elongation rate provides blown balloons with uniform wall thickness, improving overall yield and substantially reducing bursting risk.
TekniPlex Healthcare’s tri-layer inner tubing constructs are particularly sophisticated. The solutions consist of polyamide (nylon) or polyether block amide copolymer (PEBA) outer layers with high-density polyethylene (HDPE) inner layers. The small diameter, thin-wall, tight-tolerance, high-precision configurations are required for use in interventional vascular apparatuses to allow diagnostic and therapeutic devices – for example, balloon catheters for coronary, peripheral and neurovascular intervention – to more easily advance over guidewires.
TekniPlex Healthcare also will showcase its vast portfolio of PVC and TPE compounds, including samples of its broad array of medical tubing solutions made from these in-house crafted compounds. The company’s extensive capabilities and expansive capacity have yielded more than 3,000 established materials science formulations for major medical devices, whose applications run the gamut from infusion and haemodialysis to respiratory anaesthesia and intubation. Notably, TekniPlex Healthcare has nearly 60 years of medical compounding experience, with its formulations specified by several prominent global medical device companies to ensure their products’ safety and reliability.
TekniPlex Healthcare is also dedicated to developing custom solutions to unique problems in the medical technology space. The company will also showcase its paratubing, which the company can produce in up to eight custom-coloured, textured, or striped tube formations to distinguish between flow paths. Other examples include patented multilayer tubing configurations that offer extremely low absorption properties to help extend the usable life of insulin and other unstable drug products, such as chemotherapy drugs. Another patented configuration, designed for fluid transfer of DMSO and other solvent suspensions, allows for safe product delivery in dual hormone delivery systems.